DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Tygacil Drug Use Investigation

Information source: Pfizer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Intra-Abdominal Infections; Skin Disease, Infectious

Intervention: Tigecycline (Tygacil) (Drug)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer


To collect retrospectively the effectiveness and safety information of tigecycline related to their appropriate use in daily practice.

Clinical Details

Official title: Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-drug Resistance.)

Study design: Observational Model: Case-Only, Time Perspective: Retrospective

Primary outcome: Number of Participants with Clinical Response of Cure at the Test-of-Cure (TOC) Visit


Minimum age: N/A. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- All patients who are prescribed tigecycline (Tygacil).

Exclusion Criteria:

- Subject who have been prescribed tigecycline (Tygacil).

Locations and Contacts

Additional Information

To obtain contact information for a study center near you, click here.

Starting date: April 2013
Last updated: July 29, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017